Answers are grounded in this paper and cite their sources.
Elephants have about a hundred times more cells than humans and live for decades, yet they rarely die of cancer (Peto's paradox). A celebrated clue is genomic: besides the canonical $TP53$ gene, the African elephant carries 19 $TP53$ retrogenes, and its cells die more readily after DNA damage. People born with a single working copy of $TP53$ (Li--Fraumeni syndrome) have, conversely, a very high cancer risk. It is tempting to conclude that more copies simply mean more protection. We ask what extra copies can and cannot do to the dynamics of the p53 response, using a model of the p53--Mdm2 feedback loop that was fitted to the pulses of p53 measured in single human cells (model IV of Geva-Zatorsky et al., 2006). We add two parameters that describe the two things extra copies might change: the production of p53, proportional to a dosage d, and the efficiency σ with which Mdm2 targets p53 for degradation, which elephant retrogene products are reported to lower. All statements are proved with interval arithmetic. (i) In the human cell (d=σ=1) the resting level of p53 loses stability in a Hopf bifurcation when the damage signal exceeds SH∈[0.68538156083,\,0.68538156084], with period $7.85$ h at onset. (ii) Dosage alone does not move this threshold: for every d∈[1/2,\,20], from one working copy to forty, the Hopf value lies in $(0.684,\,0.687)$, while the level of p53 scales exactly as d/σ up to an additive error below 10⁻⁴. More copies make the response louder, not earlier. (iii) Escape from Mdm2 changes the kind of response: the Hopf curve obeys σ SH∈[0.6845,\,0.6854], and at a fixed damage signal $S=1$, for every d∈[1/2,\,20], p53 pulses when σ≥ 0.687 and is held at a steady, elevated level when σ≤ 0.684. In human cells pulsed p53 is associated with arrest and repair and sustained p53 with senescence and death. Within this model, therefore, twenty ordinary copies would not make a cell more willing to die; copies whose products escape Mdm2 would. This is a testable hypothesis about the dynamics of p53 in elephant cells, not a demonstration of how elephants avoid cancer. This record contains the preprint (PDF, PCI template), its LaTeX source, and the Python code and JSON certificates that reproduce every theorem, figure and number of the paper (code under the MIT licence).
No takes yet. Share an insight, caveat, or question.
Luca Eliseo Pavesi (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: